Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v7-EN
Language English English
Date Updated 2021-05-22 2021-04-01
Drug Identification Number 00500895 00500895
Brand name NALCROM NALCROM
Common or Proper name Nalcrom Nalcrom
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients CROMOLYN SODIUM CROMOLYN SODIUM
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code A07EB A07EB
ATC description INTESTINALANTIINFLAMMATORY AGENTS INTESTINALANTIINFLAMMATORY AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2021-03-31 2021-03-31
Actual start date
Estimated end date 2021-05-21 2021-04-23
Actual end date 2021-05-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments The Nalcrom shortage was due to a manufacturing delay. The extension is linked to receiving added information related to a GMP requirement. Sanofi has initiated a product allocation based on previous order history with its distributors. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Temporary shortage due to a manufacturing delay. Sanofi has initiated a product allocation based on previous order history with its distributors. Availability dates at individual distributor warehouses may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments